Drug Profile
Immune globulin - Biotest
Alternative Names: BT-595; Human normal immunoglobulin - Biotest; YimmugoLatest Information Update: 01 Dec 2022
Price :
$50
*
At a glance
- Originator Biotest Pharmaceuticals
- Developer Biotest Pharmaceuticals; Pharma Pharmaceutical Industries
- Class Anti-infectives; Anti-inflammatories; Antibacterials; Antidementias; Antifibrotics; Antivirals; Eye disorder therapies; Immunoglobulins; Immunoproteins; Serum globulins; Skin disorder therapies; Vascular disorder therapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Idiopathic thrombocytopenic purpura; Immunodeficiency disorders
Most Recent Events
- 01 Dec 2022 Preregistration for Idiopathic thrombocytopenic purpura (In the elderly, In adults) in Germany (IV)
- 01 Dec 2022 Preregistration for Idiopathic thrombocytopenic purpura in Austria (IV)
- 01 Dec 2022 Preregistration for Immunodeficiency disorders (In adolescents, In children, In the elderly, In adults) in Germany (IV)